Creation of Porous, Perfusable Microtubular Networks for Improved Cell Viability in Volumetric Hydrogels
Source abstract
Abstract
The creation of large, volumetric tissue-engineered constructs has long been hindered due to the lack of effective vascularization strategies. Recently, 3D printing has emerged as a viable approach to creating vascular structures; however, its application is limited. Here, we present a simple and controllable technique to produce porous, free-standing, perfusable tubular networks from sacrificial templates of polyelectrolyte complex and coatings of salt-containing citrate-based elastomer poly(1,8-octanediol- co -citrate) (POC). As demonstrated, fully perfusable and interconnected POC tubular networks with channel diameters ranging from 100 to 400 μm were created. Incorporating NaCl particulates into the POC coating enabled the formation of micropores (∼19 μm in diameter) in the tubular wall upon particulate leaching to increase the cross-wall fluid transport. Casting and cross-linking gelatin methacrylate (GelMA) suspended with human osteoblasts over the free-standing porous POC tubular networks led to the fabrication of 3D cell-encapsulated constructs. Compared to the constructs without POC tubular networks, those with either solid or porous wall tubular networks exhibited a significant increase in cell viability and proliferation along with healthy cell morphology, particularly those with porous networks. Taken together, the sacrificial template-assisted approach is effective to fabricate tubular networks with controllable channel diameter and patency, which can be easily incorporated into cell-encapsulated hydrogels or used as tissue-engineering scaffolds to improve cell viability.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Electrospun Nanofibers in Biomedical Applications · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Engineering, Stevens Institute of Technology, Hoboken, New Jersey 07030, United States
Semcer Center for Healthcare Innovation, Stevens Institute of Technology, Hoboken, New Jersey 07030, United States
Department of Chemical Engineering, Stevens Institute of Technology, Hoboken, New Jersey 07030, United States
Funding
Medical Research and Materiel Command · Office of Integrative Activities
References (64)
Show source-provided references
1. 10.1089/ten.tea.2019.003210.1089/ten.tea.2019.0032 ↗
2. 10.1007/s12015-019-09935-x10.1007/s12015-019-09935-x ↗
3. 10.1155/2014/92190510.1155/2014/921905 ↗
4. 10.1038/s41467-023-40006-510.1038/s41467-023-40006-5 ↗
5. 10.1146/annurev-med-102715-09233110.1146/annurev-med-102715-092331 ↗
6. 10.1177/088532821140894610.1177/0885328211408946 ↗
7. 10.3390/polym1208171710.3390/polym12081717 ↗
8. 10.1016/j.tibtech.2008.04.00910.1016/j.tibtech.2008.04.009 ↗
9. 10.1093/burnst/tkaa02210.1093/burnst/tkaa022 ↗
10. 10.1002/MBA2.1610.1002/MBA2.16 ↗
11. 10.1039/C7RA13282D10.1039/C7RA13282D ↗
12. 10.1016/J.BIOACTMAT.2021.06.03010.1016/J.BIOACTMAT.2021.06.030 ↗
13. 10.1038/SREP1987110.1038/SREP19871 ↗
14. 10.1159/00033687610.1159/000336876 ↗
15. 10.1021/acs.biomac.2c0042310.1021/acs.biomac.2c00423 ↗
16. 10.3389/fbioe.2021.66418810.3389/fbioe.2021.664188 ↗
17. 10.1016/J.BIOACTMAT.2021.02.03310.1016/J.BIOACTMAT.2021.02.033 ↗
18. 10.1016/j.biomaterials.2016.07.03810.1016/j.biomaterials.2016.07.038 ↗
19. 10.1021/acsami.0c1487110.1021/acsami.0c14871 ↗
20. 10.1039/C4LC00030G10.1039/C4LC00030G ↗
21. 10.1038/s41551-020-0566-110.1038/s41551-020-0566-1 ↗
22. 10.1016/J.BIOACTMAT.2023.06.00610.1016/J.BIOACTMAT.2023.06.006 ↗
23. 10.3390/polym1210226210.3390/polym12102262 ↗
24. 10.1177/247263031876051510.1177/2472630318760515 ↗
25. 10.1016/j.jiec.2020.04.02110.1016/j.jiec.2020.04.021 ↗
26. 10.1002/smtd.20220171710.1002/smtd.202201717 ↗
27. 10.1038/s41598-023-27901-z10.1038/s41598-023-27901-z ↗
28. 10.1016/j.bprint.2022.e0019610.1016/j.bprint.2022.e00196 ↗
29. 10.1002/jbm.a.3603610.1002/jbm.a.36036 ↗
30. 10.1016/J.BIOACTMAT.2021.02.03310.1016/J.BIOACTMAT.2021.02.033 ↗
31. 10.1038/nmat335710.1038/nmat3357 ↗
32. 10.1016/j.actbio.2020.06.01210.1016/j.actbio.2020.06.012 ↗
33. 10.1002/adhm.20210212310.1002/adhm.202102123 ↗
34. 10.1002/adma.20130550610.1002/adma.201305506 ↗
35. 10.1016/j.bioactmat.2022.01.03010.1016/j.bioactmat.2022.01.030 ↗
36. 10.1002/JBM.B.3156810.1002/JBM.B.31568 ↗
37. 10.1002/JBM.A.3121110.1002/JBM.A.31211 ↗
38. 10.1016/j.biomaterials.2005.05.10610.1016/j.biomaterials.2005.05.106 ↗
39. 10.1038/nprot.2016.03710.1038/nprot.2016.037 ↗
40. 10.1002/JBMR.565010020310.1002/JBMR.5650100203 ↗
41. 10.1002/jcb.1025910.1002/jcb.10259 ↗
42. 10.1002/adma.20030626410.1002/adma.200306264 ↗
43. 10.1063/1.503177610.1063/1.5031776 ↗
44. 10.1021/acs.jpcc.7b0388510.1021/acs.jpcc.7b03885 ↗
45. 10.3389/fbioe.2020.0018810.3389/fbioe.2020.00188 ↗
46. 10.1016/j.biomaterials.2009.09.06310.1016/j.biomaterials.2009.09.063 ↗
47. 10.3390/pharmaceutics1505134010.3390/pharmaceutics15051340 ↗
48. 10.1016/j.bioactmat.2020.08.00410.1016/j.bioactmat.2020.08.004 ↗
49. 10.1021/acsabm.8b0083310.1021/acsabm.8b00833 ↗
50. 10.3390/ma1408202310.3390/ma14082023 ↗
51. 10.14730/aaps.2022.0071010.14730/aaps.2022.00710 ↗
52. 10.1021/bm701112w10.1021/bm701112w ↗
53. 10.3389/fbioe.2020.0033610.3389/fbioe.2020.00336 ↗
54. 10.1016/j.actbio.2020.07.01610.1016/j.actbio.2020.07.016 ↗
55. 10.1089/ten.tea.2007.025510.1089/ten.tea.2007.0255 ↗
56. 10.1016/j.biomaterials.2006.08.01010.1016/j.biomaterials.2006.08.010 ↗
57. 10.1039/C4LC00030G10.1039/C4LC00030G ↗
58. 10.1038/s41427-019-0166-210.1038/s41427-019-0166-2 ↗
59. 10.1016/j.biomaterials.2008.09.03710.1016/j.biomaterials.2008.09.037 ↗
60. 10.1016/j.dental.2017.11.02010.1016/j.dental.2017.11.020 ↗
61. 10.3390/POLYM1207148910.3390/POLYM12071489 ↗
62. 10.1007/s10439-016-1662-y10.1007/s10439-016-1662-y ↗
63. 10.3389/fbioe.2022.108114510.3389/fbioe.2022.1081145 ↗
64. 10.1038/s41598-022-18075-110.1038/s41598-022-18075-1 ↗